FTC cows Sanofi into giving up on Maze licensing deal

Sanofi backed away from its drug-licensing deal with Maze Therapeutics after the Federal Trade Commission moved to block the deal.

Related Keywords

France ,French ,Jeffrey Sonnenfeld ,Lina Khan ,Lumizyme Myozyme ,Nate Soderstrom ,Amgen ,Twitter ,Justice Department ,Drug Administration ,Pfizer ,Amicus Therapeutics ,Maze Therapeutics ,Federal Trade Commission ,Leerink Partners ,Bruce Booth ,Horizon Therapeutics ,Steven Tian ,Science Ecosystem ,